Justice for whistleblower who uncovered cardiology Medicare fraud

Seeger Weiss is pleased to announce a settlement resolving allegations that the Advanced Cardiovascular Care Center P.A., including its owner and its administrator, violated the False Claims Act (FCA). The case first came to the attention of the Justice Department in 2016, when a former cardiologist with the center, represented by Seeger Weiss partner Shauna […]

November 20, 2020

Shauna Itri

Seeger Weiss is pleased to announce a settlement resolving allegations that the Advanced Cardiovascular Care Center P.A., including its owner and its administrator, violated the False Claims Act (FCA). The case first came to the attention of the Justice Department in 2016, when a former cardiologist with the center, represented by Seeger Weiss partner Shauna Itri, filed a sealed lawsuit under the FCA’s qui tam provision. That provision allows individuals who know of fraud to bring a lawsuit on behalf of the United States.

“While employed by the practice, my client spoke up about the fraud internally and was marginalized,” Itri said. “Eventually, he reported the fraud to the medical board and filed this case. Meanwhile, my client was repeatedly harassed.”

“He worked so hard to bring this wrongdoing to light, and with this settlement, he finally got justice.” Itri added. “That, to me, felt good.”

Between 2013 and 2016, Advanced Cardiovascular Care Center submitted claims to Medicare for services that were neither reasonable nor medically necessary, including cardiac external counterpulsation treatments, transthoracic echocardiography studies, and duplex scans. Though Medicare requires direct supervision over these cardiology services, the company billed the government for services under the owner, Dr. Annie T. Varughese’s, provider number when she was not in the office or even in the country.

“The largest area of fraud committed against the federal government today is by unethical healthcare providers who inflate or fabricate Medicare or Medicaid bills,” said Special Agent in Charge Perrye K. Turner of the FBI. “Billing Medicare for services that are not necessary and/or not provided constitutes fraud. American taxpayers are the ones who ultimately bear the financial burden created by this.”

The settlement, totaling $400,000, was first announced by U.S. Attorney Ryan K. Patrick.

For well over a decade, Itri has led litigation teams in complex fraud cases in both state and federal courts. Itri’s nationwide practice has focused on representing plaintiffs in various settings — including securities and consumer class actions; antitrust; and cases involving patient harm. Itri also has extensive experience representing whistleblowers in False Claims Act lawsuits and other whistleblower programs throughout the United States. She has been honored by the Philadelphia Business Journal as one of the “Best of the Bar” and by The Legal Intelligencer as a “Distinguished Leader.”

Seeger Weiss has successfully represented relators in many qui tam proceedings. The firm served as relator counsel in United States ex rel. Alexander, et al. v. Warner Chilcott plc, et al., in which $125 million was recovered in connection with a sprawling healthcare scheme. The firm also was counsel to the whistleblower in People of the State of New York, ex rel. Vijay Tharwani v. Mohanbhai Ramchandani and Mohan’s Custom Tailors, Inc., which resulted in the recovery of $5.5 million in connection with a decade — long tax evasion scheme. From its offices in New York, New Jersey, and Pennsylvania, Seeger Weiss has represented over 10,000 individuals, companies, and governments across the U.S. who have been injured or defrauded on a massive scale.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More